AVR anteris technologies global corp.

Ann: Exceptional Results in Second Valve-in-Valve Case, page-2

  1. 8,061 Posts.
    lightbulb Created with Sketch. 530
    "As Dr. Sathananthan has stated, these results do not come as a surprise. Extensive preclinical
    work in partnership with a large number of leading physicians has demonstrated a superior
    hemodynamic result compared to commercially available products, both in native aortic stenosis
    and in valve-in-valve procedures. With a rapidly growing number of degenerating AVRs, this
    valve will have a dominant role in treating these patients. “"

    $3b market just for ViV!!!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$6.00
Change
0.000(0.00%)
Mkt cap ! $92.99M
Open High Low Value Volume
$6.00 $6.06 $6.00 $12.63K 2.093K

Buyers (Bids)

No. Vol. Price($)
1 83 $6.00
 

Sellers (Offers)

Price($) Vol. No.
$6.09 1690 1
View Market Depth
Last trade - 11.30am 24/06/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.